Rac1b inhibitor (Revere Pharmaceuticals)

N/A

Report date: 2025/04/01 16:19:35
NME

Base Information

Drug NameRac1b inhibitor (Revere Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevere Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevere Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A